| Literature DB >> 30496493 |
Christian M Werner1, Anne Hecksteden2, Arne Morsch3, Joachim Zundler1, Melissa Wegmann2, Jürgen Kratzsch4, Joachim Thiery4, Mathias Hohl1, Jörg Thomas Bittenbring5, Frank Neumann5, Michael Böhm1, Tim Meyer2, Ulrich Laufs6.
Abstract
Aims: It is unknown whether different training modalities exert differential cellular effects. Telomeres and telomere-associated proteins play a major role in cellular aging with implications for global health. This prospective training study examines the effects of endurance training, interval training (IT), and resistance training (RT) on telomerase activity and telomere length (TL). Methods and results: One hundred and twenty-four healthy previously inactive individuals completed the 6 months study. Participants were randomized to three different interventions or the control condition (no change in lifestyle): aerobic endurance training (AET, continuous running), high-intensive IT (4 × 4 method), or RT (circle training on 8 devices), each intervention consisting of three 45 min training sessions per week. Maximum oxygen uptake (VO2max) was increased by all three training modalities. Telomerase activity in blood mononuclear cells was up-regulated by two- to three-fold in both endurance exercise groups (AET, IT), but not with RT. In parallel, lymphocyte, granulocyte, and leucocyte TL increased in the endurance-trained groups but not in the RT group. Magnet-activated cell sorting with telomerase repeat-ampliflication protocol (MACS-TRAP) assays revealed that a single bout of endurance training-but not RT-acutely increased telomerase activity in CD14+ and in CD34+ leucocytes.Entities:
Year: 2019 PMID: 30496493 PMCID: PMC6312574 DOI: 10.1093/eurheartj/ehy585
Source DB: PubMed Journal: Eur Heart J ISSN: 0195-668X Impact factor: 29.983
Effects of 6 months training on clinical parameters and physical fitness
| Co | Aerobic endurance training | Interval training | Resistance training | ||||
|---|---|---|---|---|---|---|---|
| Δ post vs. pre | Δ post vs. pre | Δ post vs. pre | Δ post vs. pre | ||||
| Clinical parameters | |||||||
| BMI (kg/m2) | 0.0 (0.8) | −0.5 (1.0) | −0.5 (0.9) | −0.2 (0.8) | 0.18 | ||
| Systolic BP (mmHg) | 2.7 (11.1) | −1.3 (12.2) | 0.20 | 1.8 (9.7) | 0.75 | −3.2 (9.4) | |
| Diastolic BP (mmHg) | 0.0 (7.3) | −2.2 (8.5) | 0.28 | −1.8 (5.3) | 0.29 | −2.8 (8.3) | 0.14 |
| Resting HR (b.p.m.) | −2.7 (6.0) | −5.4 (6.2) | 0.11 | −6.8 (7.3) | −6.0 (8.1) | 0.07 | |
| Fasting glucose (mg/dL) | −0.7 (9.3) | −3.4 (6.2) | 0.21 | 0.2 (7.1) | 0.67 | −0.7 (7.3) | 0.97 |
| Fasting insulin (µIU/mL) | 0.06 (2.23) | −0.31 (1.59) | 0.47 | −0.55 (2.28) | 0.29 | −0.37 (1.91) | 0.39 |
| Total cholesterol | 3.6 (25.5) | −10.62 (19.6) | 1.21 (21.5) | 0.69 | 3.09 (28.8) | 0.94 | |
| Treadmill stress test | |||||||
| Peak heart rate (b.p.m.) | 1.1 (6.0) | −2.5 (7.8) | 0.06 | −4.8 (5.2) | 0.2 (6.1) | 0.56 | |
| VO2max (mL/min/kg) | −1.0 (3.1) | 2.7 (3.7) | 2.8 (5.1) | 3.0 (5.9) | |||
| Maximum speed (km/h) | −0.1 (0.6) | 1.1 (0.6) | 1.4 (0.6) | 0.4 (0.7) | |||
| At 130 b.p.m. | 0.2 (0.4) | 0.4 (0.6) | 0.6 (0.5) | 0.2 (0.4) | 0.82 | ||
| At 150 b.p.m. | 0.2 (0.4) | 0.7 (0.7) | 1.0 (0.5) | 0.2 (0.4) | 0.98 | ||
| At lactate 2 mmol/L | −0.1 (0.6) | 0.8 (0.6) | 0.5 (0.7) | −1.0 (0.5) | 0.94 | ||
| RER | −0.04 (0.10) | −0.02 (0.12) | 0.45 | 0.00 (0.16) | 0.24 | −0.10 (0.13) | |
Data are represented as mean (SD).
Significant differences to pre time-point (2-way ANOVA) are in bold face.
b.p.m., beats per minute; BMI, body mass index; BP, blood pressure; Co, control group; HR, heart rate; RER, respiratory exchange ratio.
Take home figureIn a primary prevention cohort of untrained healthy middle-aged subjects, aerobic endurance training, or intensive interval training for 6 months increased telomerase activity and telomere length, indicating vascular anti-aging effects. No changes were observed in the control and resistance training groups.
Baseline characteristics in the prospective 6 months training study
| Control group | Aerobic endurance training | Interval training | Resistance training | ||
|---|---|---|---|---|---|
| 35 | 26 | 29 | 34 | ||
| Gender (M/F) | 12/23 | 9/17 | 10/19 | 14/20 | |
| Age (years) | 50.2 (7.4) | 49.5 (7.0) | 48.4 (6.5) | 48.1 (7.5) | 0.61 |
| Clinical characteristics | |||||
| Body mass index (kg/m2) | 24.2 (3.1) | 23.8 (3.3) | 24.5 (3.0) | 24.8 (3.4) | 0.64 |
| Systolic BP (mmHg) | 131 (16) | 132 (15) | 125 (27) | 132 (13) | 0.35 |
| Diastolic BP (mmHg) | 84 (10) | 86 (11) | 82 (17) | 86 (7) | 0.63 |
| Resting heart rate (b.p.m.) | 64 (10) | 65 (8) | 68 (11) | 67 (9) | 0.32 |
| Clinical chemistry | |||||
| Fasting glucose (mg/dL) | 96 (9) | 96 (6) | 98 (8) | 96 (8) | 0.44 |
| Fasting insulin (µIU/mL) | 4.60 (2.2) | 4.48 (2.3) | 6.11 (2.6) | 5.19 (2.6) | 0.05 |
| Total cholesterol (mg/dL) | 212 (40) | 224 (43) | 212 (36) | 206 (44) | 0.41 |
| HDL cholesterol (mg/dL) | 55 (20) | 58 (21) | 53 (17) | 56 (16) | 0.77 |
| LDL cholesterol (mg/dL) | 105 (31) | 114 (36) | 106 (32) | 102 (32) | 0.59 |
| Treadmill stress test | |||||
| Peak heart rate (b.p.m.) | 178 (13) | 183 (10) | 178 (10) | 182 (11) | 0.19 |
| VO2max (mL/min/kg) | 35.1 (5.3) | 35.3 (6.3) | 35.1 (5.0) | 35.3 (5.3) | 0.99 |
| Maximum speed (km/h) | 10.0 (1.5) | 9.9 (1.6) | 10.0 (1.2) | 10.0 (1.5) | 0.99 |
| At 130 b.p.m. | 5.5 (2.4) | 4.5 (3.1) | 4.5 (2.8) | 5.6 (1.9) | 0.14 |
| At 150 b.p.m. | 7.2 (1.3) | 7.2 (0.9) | 6.9 (0.6) | 7.2 (1.1) | 0.56 |
| At lactate 2 mmol/L | 4.9 (3.0) | 4.6 (3.2) | 4.7 (3.0) | 5.3 (2.6) | 0.82 |
| Respiratory exchange rate | 1.17 (0.10) | 1.12 (0.09) | 1.10 (0.13) | 1.11 (0.22) | 0.28 |
Data are represented as mean (SD).
BP, blood pressure; b.p.m., beats per minute; F, female; M, male; VO2max, maximum oxygen uptake.